GREY:NPCUF - Post by User
Post by
diadon1945on Dec 12, 2012 3:48pm
216 Views
Post# 20721310
NEW FDA APPROVAL PATH
NEW FDA APPROVAL PATH Allon's drug has all the bells and whistles from the FDA.Orphan status, fast track and Special Protocol Assessment....so it should be approved quickly...and with special tax and patent benefits. But there is also something new.
Breakthrough drug pathway
12/02/2012 BioCentury interview with Janet Woodcock.
https://www.biocenturytv.com/player/2000894425001/2003420183001